These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1532417)

  • 1. Brain muscarinic cholinergic receptors in Huntington's disease.
    Lange KW; Javoy-Agid F; Agid Y; Jenner P; Marsden CD
    J Neurol; 1992 Feb; 239(2):103-4. PubMed ID: 1532417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in brain muscarinic cholinergic receptor binding and choline acetyltransferase activity in Huntington's disease.
    Wastek GJ; Johnson PC; Stern LZ; Yamamura HI
    Proc West Pharmacol Soc; 1976; 19():170-1. PubMed ID: 136659
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-related differences in brain choline acetyltransferase, cholinesterases and muscarinic receptor sites in two strains of rats.
    Michalek H; Fortuna S; Pintor A
    Neurobiol Aging; 1989; 10(2):143-8. PubMed ID: 2725809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease: regional alteration in muscarinic cholinergic receptor binding in human brain.
    Wastek GJ; Stern LZ; Johnson PC; Yamamura HI
    Life Sci; 1976 Oct; 19(7):1033-9. PubMed ID: 136582
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 6. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors.
    Vilaró MT; Mengod G; Palacios JM
    Prog Brain Res; 1993; 98():95-101. PubMed ID: 8248542
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic markers in ALS spinal cord.
    Berger ML; Veitl M; Malessa S; Sluga E; Hornykiewicz O
    J Neurol Sci; 1992 Mar; 108(1):114-7. PubMed ID: 1624947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma choline and cholinergic mechanisms in the brain. Methods, function, and rôle in Huntington's chorea.
    Eckernäs SA
    Acta Physiol Scand Suppl; 1977; 449():1-62. PubMed ID: 143869
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic neuronal defect without cell loss in Huntington's disease.
    Smith R; Chung H; Rundquist S; Maat-Schieman ML; Colgan L; Englund E; Liu YJ; Roos RA; Faull RL; Brundin P; Li JY
    Hum Mol Genet; 2006 Nov; 15(21):3119-31. PubMed ID: 16987871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology and pharmacology of Huntington's disease.
    Enna SJ
    Life Sci; 1977 Jan; 20(2):205-11. PubMed ID: 190505
    [No Abstract]   [Full Text] [Related]  

  • 13. NMDA receptor losses in putamen from patients with Huntington's disease.
    Young AB; Greenamyre JT; Hollingsworth Z; Albin R; D'Amato C; Shoulson I; Penney JB
    Science; 1988 Aug; 241(4868):981-3. PubMed ID: 2841762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes.
    Svensson AL; Warpman U; Hellström-Lindahl E; Bogdanovic N; Lannfelt L; Nordberg A
    Neurosci Lett; 1997 Aug; 232(1):37-40. PubMed ID: 9292886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative distribution of muscarinic receptors and choline acetyltransferase in rat medulla: examination of transmitter-receptor mismatch.
    Ernsberger P; Arneric SP; Arango V; Reis DJ
    Brain Res; 1988 Jun; 452(1-2):336-44. PubMed ID: 3401740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the morphology of the septo-hippocampal cholinergic and GABAergic system in mice. I. Cholinergic and GABAergic markers.
    Schwegler H; Boldyreva M; Pyrlik-Göhlmann M; Linke R; Wu J; Zilles K
    Hippocampus; 1996; 6(2):136-48. PubMed ID: 8797015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of choline acetyltransferase activity but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury: a preliminary human postmortem study.
    Dewar D; Graham DI
    J Neurotrauma; 1996 Apr; 13(4):181-7. PubMed ID: 8860198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.
    Nordberg A; Nyberg P; Windblad B
    Neurochem Pathol; 1985; 3(4):223-36. PubMed ID: 3831845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.
    Nordberg A; Alafuzoff I; Winblad B
    J Neurosci Res; 1992 Jan; 31(1):103-11. PubMed ID: 1613816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.